Plenary

Lipoprotein(a): The (Wholly Underappreciated) New Marker of Cardiovascular Risk (Lunch Available in Foyer)

Saturday, October 11, 2025

12:30 PM - 1:30 PM East Coast USA Time

Location: Calusa 1-6

Speaker(s)

Robert J. Chilton, DO, MACOI

Professor of Medicine
University of Texas Health Science Center

Moderator(s)

Tiffany Di Pietro, DO, FACOI (she/her/hers)

Founder/CEO
Di Pietro Health
Fort Lauderdale, Florida, United States

Measure once in life JAMA Cardiol. doi:10.1001/jamacardio.2024.1874
JAMA Cardiol. doi:10.1001/jamacardio.July 2024.1874
JACC O C T O B E R 7 , 2 0 2 5: 1 0 4 6 – 1 0 5 6

Learning Objectives:

Explain the genetic determinants that influence lipoprotein(a) structure and plasma concentration.
Describe how recent advances in translational biology have improved understanding of lipoprotein(a)’s role in cardiovascular disease.
Evaluate emerging clinical trial data assessing novel therapies targeting lipoprotein(a) reduction.